Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran Post author:Sam Post published:December 14, 2017 Post category:BioPharma Clinical trial dosing will resume around year-end 2017. Source: BioSpace You Might Also Like Aldeyra Therapeutics Inks Collaboration Deal with Johnson & Johnson to Develop Anti-inflammatory … February 26, 2018 Novartis AG Puts Cancer Hopes on 4 Star Scientists Poached From Harvard Last Year February 28, 2017 3 Tiny Biotechs That Could Catch Fire Soon October 1, 2017
Aldeyra Therapeutics Inks Collaboration Deal with Johnson & Johnson to Develop Anti-inflammatory … February 26, 2018
